This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including the S1P drug treatment class. There are also inequities relating to the level of care white patients with MS receive compared to non-white patients with MS, especially African Americans and Hispanic-Latinx. This program educates clinicians on the racial and ethnic disparities that produce barriers for minorities concerning MS diagnosis and treatment and helps close the gap.

This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including the S1P drug treatment class. There are also inequities relating to the level of care white patients with MS receive compared to non-white patients with MS, especially African Americans and Hispanic-Latinx. This program educates clinicians on the racial and ethnic disparities that produce barriers for minorities concerning MS diagnosis and treatment and helps close the gap.

Drs. Modi and Wykoff discuss two cases: a patient who is unhappy with the results of his cataract surgery and a 90-year-old who is seeking cataract clearance.

Management of neurotrophic keratitis (NK) is based on disease severity. During this webinar, the faculty members discuss updated viewpoints on what truly constitutes stage 1 disease as well as NK diagnostic strategies, treatment of stage 1 NK to prevent progression, and novel therapies.

This content was captured during a synchronous virtual symposium. Polling took place during the symposium.

Dr. Chang presents two cases: a patient who is experiencing progressive reading problems and a patient who is experiencing difficulty with driving.

Drs. Modi and Wykoff discuss a case of a surgeon with blind spots in his vision.

Thyroid eye disease (TED) is the most common noninfectious, autoimmune disease that leads to inflammation and enlargement of the orbital and retro-orbital muscles and connective and fat tissues.

Drs. Kossler, Murdock, and Bloomgarden discuss how to recognize the signs and symptoms of this complex disease and effective comanagement strategies to improve outcomes for patients with TED.

Dr. Goldberg presents two cases: an 111-year-old patient who presents for a dry age-related macular degeneration follow-up and a patient with geographic atrophy who also has advanced glaucoma and a history of retinal detachment.

Dr. Goldberg presents two cases: a patient with foveal-involving geographic atrophy and a patient with geographic atrophy who developed exudative age-related macular degeneration.

This program examines the significant challenges encompassing the management of Multiple Sclerosis (MS), including the need for quick and effective screening tools to help clinicians increase early diagnosis and the initiation of therapy. While there is currently no cure for MS, the treatment landscape is rapidly changing, and this program provides a review of best practice guidelines and emerging treatment strategies, including the S1P drug treatment class. There are also inequities relating to the level of care white patients with MS receive compared to non-white patients with MS, especially African Americans and Hispanic-Latinx. This program educates clinicians on the racial and ethnic disparities that produce barriers for minorities concerning MS diagnosis and treatment and helps close the gap.